Similar articles

• IV Versus Subcutaneous Enoxaparin in Critically Ill Infants and Children: Comparison of Dosing, Anticoagulation Quality, Efficacy, and Safety Outcomes.

  Diab YA, Ramakrishnan K, Ferrell B, Chounoune R, Alfares FA, Endicott KM, Rooney S, Corcoran J, Zurakowski D, Berger JT, Shankar V, Nath DS. Diab YA, et al. Pediatr Crit Care Med. 2017 May;18(5):e207-e214. doi: 10.1097/PCC.0000000000001126. Pediatr Crit Care Med. 2017. PMID: 28296662
• Experience with intravenous enoxaparin in critically ill infants and children.

  Crary SE, Van Orden H, Journeycake JM. Crary SE, et al. Pediatr Crit Care Med. 2008 Nov;9(6):647-9. doi: 10.1097/PCC.0b013e31818d1920. Pediatr Crit Care Med. 2008. PMID: 18838932
• Arterial line versus venous line administration of low molecular weight heparin, enoxaparin for prevention of thrombosis in the extracorporeal blood circuit of patients on haemodialysis or haemodiafiltration: A randomized cross-over trial.

  Kurtkoti J, Bose B, Hiremagalur B, Sun J, Cochrane T. Kurtkoti J, et al. Nephrology (Carlton). 2016 Aug;21(8):663-8. doi: 10.1111/nep.12681. Nephrology (Carlton). 2016. PMID: 26609786 Clinical Trial.
• Enoxaparin: a review of its use as thromboprophylaxis in acutely ill, nonsurgical patients.

  Siddiqui MA, Wagstaff AJ. Siddiqui MA, et al. Drugs. 2005;65(7):1025-36. doi: 10.2165/00003495-200565070-00009. Drugs. 2005. PMID: 15892594 Review.
• A world of low molecular weight heparins (LMWHs) enoxaparin as a promising moiety--a review.

  Ingle RG, Agarwal AS. Ingle RG, et al. Carbohydr Polym. 2014 Jun 15;106:148-53. doi: 10.1016/j.carbpol.2014.01.100. Epub 2014 Feb 18. Carbohydr Polym. 2014. PMID: 24721062 Review.